A key component to success in structure-based drug design is reliable information on protein-ligand interactions. Recent development in NMR techniques has accelerated this process by overcoming some of the limitations of X-ray crystallography and computational protein-ligand docking. In this work we present a new scoring protocol based on NMR-derived interligand INPHARMA NOEs to guide the selection of computationally generated docking modes. We demonstrate the performance in a range of scenarios, encompassing traditionally difficult cases such as docking to homology models and ligand dependent domain rearrangements. Ambiguities associated with sparse experimental information are lifted by searching a consensus solution based on simultaneous...
Accurate prediction of protein-ligand interactions and the associated binding affinity is a major ta...
Structure-based drug design is routinely used in modern day drug discovery. However, the success of ...
Protein binding sites undergo ligand specific conformational changes upon ligand binding. However, m...
A key component to success in structure-based drug design is reliable information on protein-ligand ...
A key component to success in structure-based drug design is reliable information on protein-ligand ...
A key component to success in structure-based drug design is reliable information on protein-ligand ...
A key component to success in structure-based drug design is reliable information on protein–ligand ...
Abstract Low-affinity ligands can be efficiently opti-mized into high-affinity drug leads by structu...
Structure-based drug design is an integral part of modern day drug discovery and requires detailed s...
A well studied problem in the area of Computational Molecular Biology is the so-called Protein-Prote...
INPHARMA (interligand nuclear Overhauser enhancement for pharmacophore mapping) determines the relat...
Molecular recognition is at the base of all biological events and its knowledge at atomic level is p...
Molecular recognition is at the base of all biological events and its knowledge at atomic level is p...
Despite recent advances in the modeling of protein-protein complexes by docking, additional informat...
International audienceDespite recent advances in the modeling of protein-protein complexes by dockin...
Accurate prediction of protein-ligand interactions and the associated binding affinity is a major ta...
Structure-based drug design is routinely used in modern day drug discovery. However, the success of ...
Protein binding sites undergo ligand specific conformational changes upon ligand binding. However, m...
A key component to success in structure-based drug design is reliable information on protein-ligand ...
A key component to success in structure-based drug design is reliable information on protein-ligand ...
A key component to success in structure-based drug design is reliable information on protein-ligand ...
A key component to success in structure-based drug design is reliable information on protein–ligand ...
Abstract Low-affinity ligands can be efficiently opti-mized into high-affinity drug leads by structu...
Structure-based drug design is an integral part of modern day drug discovery and requires detailed s...
A well studied problem in the area of Computational Molecular Biology is the so-called Protein-Prote...
INPHARMA (interligand nuclear Overhauser enhancement for pharmacophore mapping) determines the relat...
Molecular recognition is at the base of all biological events and its knowledge at atomic level is p...
Molecular recognition is at the base of all biological events and its knowledge at atomic level is p...
Despite recent advances in the modeling of protein-protein complexes by docking, additional informat...
International audienceDespite recent advances in the modeling of protein-protein complexes by dockin...
Accurate prediction of protein-ligand interactions and the associated binding affinity is a major ta...
Structure-based drug design is routinely used in modern day drug discovery. However, the success of ...
Protein binding sites undergo ligand specific conformational changes upon ligand binding. However, m...